SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
Stifel Nicolaus 2011 Healthcare Conference | |||
Date: | Wednesday, September 7, 2011 | ||
Time: | 1:30pm Eastern Time (10:30am Pacific Time) | ||
Place: | Four Seasons Hotel in Boston | ||
Speaker: | Scott Byrd, SVP & Chief Commercial Officer | ||
UBS Global Life Sciences Conference | |||
Date: | Tuesday, September 20, 2011 | ||
Time: | 11:30am Eastern Time (8:30am Pacific Time) | ||
Place: | Grand Hyatt Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
JMP Securities Healthcare Conference | |||
Date: | Wednesday, September 28, 2011 | ||
Time: | 9:30am Eastern Time (6:30am Pacific Time) | ||
Place: | The St. Regis Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 | |
SOURCE Cadence Pharmaceuticals, Inc.
